The UN adoption of the SDGs in 2015 signaled a strong commitment of member countries to the expanded access to essential health service agenda and definitively recognized the critical role of medicines in achieving UHC. The SDGs call for countries to “achieve universal health coverage, including financial risk protection, access to quality essential health care services and access to safe, effective, quality and affordable essential medicines and vaccines for all”. This paper seeks to highlight the key functional areas of pharmaceutical management, the critical components of the pharmaceutical system, and the management considerations needed to facilitate the attainment of UHC targets.
Pharmaceutical management considerations for expanded coverage of essential health services and financial protection programs
Ethiopian National Health Insurance Scale-Up Assessment on Medicines Financing, Use, and Benefit Management
An assessment on current pharmaceutical financing, SHI and CBHI medicines coverage, and public and private sector medicines prescribing and dispensing and their costs was conducted. The SCMS program conducted an assessment that addressed the supply chain and public-private partnership implications of the expected increased demand for quality medicines and related health supplies.
This report presents the findings from the SIAPS assessment, the implications for preparing a proof of concept for launching and implementing the SHI scheme, and the potential for opportunities to engage the private sector.
Leveraging Private Pharmaceutical Sector Capacity Toward Achieving Sustainable UHC in Low- and Middle-Income Countries
By Kwesi Eghan, SIAPS Principal Technical Advisor, Pharmaceutical Systems Cluster Universal health coverage (UHC) in low- and middle-income countries (LMICs) requires government-led public financing. However, the financing capacity of most LMICs is already stretched thin, between the demands for population coverage, quality service, reduced out-of-pocket payments, and other societal funding requirements. To meet this challenge, mechanisms […]
SIAPS Presents on OSPSANTE and OSPSIDA at WHO Francophone Technical Briefing Seminar on Medicine Policy 2016
The World Health Organization Department of Essential Medicines and Health Products invited SIAPS to participate in its annual French Technical Briefing Seminar, held 9-13 May, in Geneva, Switzerland. The seminar, held every year since 1998, brings together experts working in the pharmaceutical and health sector programs in francophone countries, around current and topical issues related […]
Delegates at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, agreed upon and issued a Call to Action against antimicrobial resistance during the biannual meeting, held 18-21 May 2016, in Tubingen, Germany. EPN, a partner of the USAID-funded SIAPS Program, issued the renewed call to action with support from SIAPS and other partners. The Call to […]
Governments should not have to “break the bank” while working to achieve universal access to quality-assured and affordable essential medicines and vaccines for all, SIAPS Principal Technical Advisor Niranjan Konduri wrote in a Devex op-ed this week. Reacting to the WHO’s first global report on diabetes, released on April 6, Konduri identified inefficient government spending on pharmaceutical commodities as […]
By Francis Aboagye-Nyame, Program Director, SIAPS Three years ago, the United Nations unanimously passed a resolution that endorsed the concept of universal health coverage. The USAID-funded SIAPS Program, along with hundreds of other partners in the global health community, now marks that landmark commitment by commemorating each December 12th as Universal Health Coverage Day. This […]
By Francis Aboagye-Nyame, Program Director, SIAPS On Friday, December 12, over 500 partners from the global health community will come together to commemorate the first Universal Health Coverage (UHC) Day. Although marking the day is new, support for the concept has been building for several years – and momentum for it continues to grow. Dr. […]
From September 28 to 30, 2014, global experts will convene in Cape Town, South Africa, in a meeting organized by Management Sciences for Health (MSH) with funding from SIAPS to start a dialogue on medicines and universal health coverage (UHC). At last year’s meeting, it became clear that many national UHC plans do not give priority […]
Improving Medicines Benefit Management for Universal Health Coverage Programs: A Conversation with Kwesi Eghan
Reposted from msh.org. Used appropriately, medicines save lives, decrease effect or cure diseases, and improve quality of life. Medicines are also key determinants of health care quality, and can be among the most cost-effective uses of scarce health care resources. At the same time, management of medicines is a major source of inefficiencies in health care […]
The 3rd Biennial Scientific Conference on Medical Products Regulation in Africa (SCOMRA), which took place November 27–28, 2017, in Accra, […]
The director of the Department of Pharmacy, Medicines, and Diagnostics (DPMED) wishes to adopt suitable software to strengthen the registration system […]
In the last five years, SIAPS has provided technical assistance to the Namibia Medicines Regulatory Council (NMRC) to strengthen its capacity […]